Gastric Banding: Ethical Dilemmas in Reviewing Body Mass Index Thresholds

October 2011
Mayo Clinic Proceedings;Oct2011, Vol. 86 Issue 10, p999
Academic Journal
In this article the author discusses the U.S. Food and Drug Administration's (FDA) revised indication of gastric banding. She states the FDA has reduced the body mass index (BMI) threshold for obesity related health patients. She states the revised indication has received a mixed review from the people of the U.S. She states alongside clinical data ethical issues should be considered in gastric banding, including, patient autonomy, weight related stigma and discrimination.


Related Articles

  • Davis Clinic Set to Perform LAP-BAND(r) System Surgery in Patient with Body Mass Index Below 35.  // Biomedical Market Newsletter;7/5/2011, p600 

    The article reports on the June 27, 2011 announcement of Houston, Texas-based The Davis Clinic that it will start offering the LAP-BAND System in obesity patients with a body mass index (BMI) ranging from 30-35. It states that the LAP-Band System was approved by the U.S. Food & Drug...

  • Weight loss surgery is safe & effective for an expanded group of patients.  // Pulse International;5/31/2013, Vol. 14 Issue 10, p5 

    The article reports on a study which suggests that the LAP-BAND gastric banding (LAGB) weight loss procedure is safe and effective for certain groups of patients. Researcher Robert Michaelson reveals that the LAGB has been approved by the Food and Drug Administration (FDA) for patients with...

  • Bariatric surgery guidelines in need of revision, experts argue. Senger, Emily // CMAJ: Canadian Medical Association Journal;3/8/2011, Vol. 183 Issue 4, pE234 

    The article focuses on the need to revise the guidelines for bariatric surgery in the U.S. Doctor John Kral from the State University of New York (SUNY) Downstate Medical Center says that the required minimum body mass index (BMI) of 40, or a BMI of 35 with one or more severe comorbidities in...

  • Third weight-loss drug approved for obese, overweight adults. Talsma, Julia // Drug Topics;Oct2014, Vol. 158 Issue 10, p38 

    The article reports the approval of Contrave by the Food and Drug Administration (FDA) for use by obese and overweight adults who need to lose weight. Contrave is a weight management drug that combines naltrexone HCl and bupropion HCl in an extended-release formulation and prescribed for...

  • Short-Term Outcomes of Laparoscopic Gastric Plication in Morbidly Obese Patients: Importance of Postoperative Follow-up. Niazi, Mani; Maleki, Ali; Talebpour, Mohammad // Obesity Surgery;Jan2013, Vol. 23 Issue 1, p87 

    Demand for feasible, safe, and preferably low-cost methods of weight reduction is rising every day. The present study reports findings from laparoscopic gastric plication (LGP), which is a new restrictive bariatric technique, combined with a postoperative follow-up program. A 2-year prospective...

  • Assessing the outcomes and complications of gastric banding with mesh in morbid obesity in Kashan Shahid Beheshti hospital during 2007-9. Kalidari, B.; Khaleghian, M.; Arbabi, M.; Mousavi, G. A. // Feyz Journal of Kashan University of Medical Sciences;Sep2010, Vol. 14 Issue 3, p66 

    Background: Patients with morbid obesity have different signs .The overall morbidity rate among the patients with 50% over-weigh is twice. Many types of operations are invented to overcome the problem, one of which is gastric banding with mesh. Materials and Methods: Thirty patients treated with...

  • Association Between Bariatric Surgery and Long-term Survival. Arterburn, David E.; Olsen, Maren K.; Smith, Valerie A.; Livingston, Edward H.; Van Scoyoc, Lynn; Yancy Jr., William S.; Eid, George; Weidenbacher, Hollis; Maciejewski, Matthew L. // JAMA: Journal of the American Medical Association;1/6/2015, Vol. 313 Issue 1, p62 

    IMPORTANCE Accumulating evidence suggests that bariatric surgery improves survival among patients with severe obesity, but research among veterans has shown no evidence of benefit. OBJECTIVE To examine long-term survival in a large multisite cohort of patients who underwent bariatric surgery...

  • FDA issues warnings over Lap-Band promotions. McCarthy, Mark // Medical Device Daily;12/15/2011, Vol. 15 Issue 239, p7 

    The article reports that U.S. Food and Drug Administration (FDA) warned the California state government in promoting Lap-Band in the state due to lack of facts that prove its health benefits.

  • Effectiveness of Bariatric Surgery in Reducing Weight and Body Mass Index Among Hispanic Adolescents. Cruz-Muñoz, Nestor; Lopez-Mitnik, Gabriela; Arheart, Kristopher; Miller, Tracie; Lipshultz, Steven; Messiah, Sarah // Obesity Surgery;Feb2013, Vol. 23 Issue 2, p150 

    Background: Ethnic minority adolescents, Hispanics in particular, are disproportionately affected by extreme obesity and its associated co-morbidities. Bariatric surgery is one of the few effective treatments for morbid obesity, yet little information about weight outcomes after surgery in this...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics